DouglasWLosordoMD
Cardiology • New York, NYExecutive Vice President, Global Head of R&D, Chief Medical Officer.
Dr. Losordo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
420 Lexington Ave
New York, NY 10011- Is this information wrong?
Education & Training
St Elizabeth's Medical CenterResidency, Internal Medicine, 1983 - 1986
University of Vermont College of MedicineClass of 1983- St Elizabeth's Medical CenterFellowship, Cardiovascular Disease
Certifications & Licensure
NY State Medical License 2014 - 2025
IL State Medical License 2007 - 2020
MA State Medical License 1984 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
- Super Doctor SuperDoctors.com
Clinical Trials
- VEGF Gene Transfer for Diabetic Neuropathy Start of enrollment: 2002 Dec 01
- Stem Cell Mobilization and VEGF Gene Transfer for Heart Failure Start of enrollment: 2008 Jul 01
- VEGF Gene Transfer for Critical Limb Ischemia
- Join now to see all
Publications & Presentations
PubMed
- 12 citationsAutologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular Dysfunction.Timothy D Henry, C Noel Bairey Merz, Janet Wei, Michel T Corban, Odayme Quesada, Sandy Joung, Christine L Kotynski, Jian Wang, Michelle Lewis, Ann M Schumacher, Ronnda...> ;Circulation. Cardiovascular Interventions. 2022 Feb 1
- 5 citationsPrevention and Recovery of Hibernating Myocardium by Microvascular RepairMarc Z. Krichavsky, Douglas W. Losordo> ;Circulation. 2011 Aug 30
- 13 citationsCD34+ cell therapy significantly reduces adverse cardiac events, health care expenditures, and mortality in patients with refractory angina.Grace L. Johnson, Timothy D. Henry, Thomas J. Povsic, Douglas W. Losordo, Ross Garberich, Larissa Stanberry, Craig Strauss, Jay H. Traverse> ;Stem Cells Translational Medicine. 2020 Jun 12
- Join now to see all
Press Mentions
Caladrius Biosciences Announces the Resignation of Dr. Douglas Losordo, Chief Medical OfficerNovember 17th, 2020
AHA: Caladrius Single Injection Helps Heart Disease That Hits Women the HardestNovember 18th, 2019
Caladrius Biosciences Reports Positive Results for CLBS16 from the ESCaPE-CMD Trial at American Heart Association Scientific Sessions 2019November 16th, 2019- Join now to see all
Grant Support
- Small Animal Surgery And HistologyNational Heart, Lung, And Blood Institute2012
- Role Of PAI-1 In Cardiovascular Repair And FibrosisNational Heart, Lung, And Blood Institute2012
- Peptide Amphiphiles To Augment Progentitor Cell TherapiesNational Heart, Lung, And Blood Institute2012
- Mitochondrial Defects In Epcs In Diabetes And AgingNational Heart, Lung, And Blood Institute2012
- FACS Analysis And Cell SortingNational Heart, Lung, And Blood Institute2012
- Epigenetic Modulation Of EPC For CardiomyogenesisNational Heart, Lung, And Blood Institute2012
- Advanced Molecular ImagingNational Heart, Lung, And Blood Institute2012
- Administrative CoreNational Heart, Lung, And Blood Institute2012
- Therapeutic Angiogenesis In Vascular Medicine IVNational Heart, Lung, And Blood Institute2011
- Novel Approaches To Ischemic Tissue RepairNational Heart, Lung, And Blood Institute2011
- Cardiovascular Regenerative MedicineNational Heart, Lung, And Blood Institute2011
- Autologous CD34+ Cell Therapy For Therapeutic Angiogenesis In Advanced PADNational Heart, Lung, And Blood Institute2011
- Therapeutic Angiogenesis In Vascular Medicine IIINational Heart, Lung, And Blood Institute2009–2010
- Novel Approaches To Ischemic Tissue RepairNational Heart, Lung, And Blood Institute2009–2010
- Role Of Progenitor Cells In Cardiovascular MedicineNational Heart, Lung, And Blood Institute2007–2010
- Autologous CD34+ Cell Therapy For Therapeutic Angiogenesis In Advanced PADNational Heart, Lung, And Blood Institute2007–2010
- Progenitor Cells In Vascular BiologyNational Heart, Lung, And Blood Institute2007–2008
- Restenosis And Endothelial ProliferationNational Heart, Lung, And Blood Institute2007
- Role Of Progenitor Cells In Cardiovascular MedicineNational Heart, Lung, And Blood Institute2006
- Autologous CD34+ Cell Therapy For Therapeutic Angiogenesis In Advanced PADNational Heart, Lung, And Blood Institute2006
- Progenitor Cells In Vascular BiologyNational Heart, Lung, And Blood Institute2005–2006
- Restenosis And Endothelial ProliferationNational Heart, Lung, And Blood Institute1999–2006
- VEGF Gene Transfer To Prevent Coronary Artery RestenosisNational Heart, Lung, And Blood Institute2001–2005
- Core--TrainingNational Heart, Lung, And Blood Institute2001–2005
- Therapeutic Angiogenesis In Vascular Medicine IINational Heart, Lung, And Blood Institute2002–2004
- Center Of Excellence In Gene Therapy(Program Project)National Heart, Lung, And Blood Institute2002–2004
- Re-Endothelialization And Restenosis IINational Heart, Lung, And Blood Institute2001–2004
- Estrogen, Angiogenesis And Endothelial Progenitor CellsNational Heart, Lung, And Blood Institute2001–2004
- Estrogen For Prevention Of Restenosis In Older WomenNational Institute On Aging1999–2000
Professional Memberships
- Fellow
- Fellow
- Society for Cardiovascular Angiography and InterventionsFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
